Supernus Pharmaceuticals | SUPN - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Abbott USD 1.74B 23.39B 2025-09
ANI Pharmaceuticals USD 22.49M 760K 2025-12
Aurora Cannabis CAD 56.71M 134.13K 2025-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Canopy Growth CAD 368.28M 35.9M 2025-12
Cara Therapeutics USD 9.38M 9.38M 2025-09
Corcept Therapeutics USD 107.33M 1.36M 2026-03
Eisai JPY 282.11M 0 2026-03
Eli Lilly USD 943.5M 3.33M 2026-03
Novo Nordisk DKK 4.44B 0 2025-12
Pacira USD 39.31M 1.81M 2026-03
Perrigo USD 138.1M 500K 2026-03
Pfizer USD 5.7B 13M 2026-03
Supernus Pharmaceuticals USD 58.04M 582K 2026-03
United Therapeutics USD 42.16M 1.49M 2026-03
Xeris Pharmaceuticals USD 166.22M 687.16K 2025-12